What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Antibody
Her primary areas of study are Immunology, Molecular biology, Bone marrow, Pathology and Cytotoxic T cell.
Her work carried out in the field of Immunology brings together such families of science as Painful skin and Disease.
Her Molecular biology research incorporates elements of Cell culture and Monoclonal antibody.
Her study in Bone marrow is interdisciplinary in nature, drawing from both Haematopoiesis, Betaherpesvirinae, Leukemia, Mesenchymal stem cell and Acute lymphocytic leukemia.
Her work on Fibrosis as part of general Pathology research is frequently linked to Immunostaining, thereby connecting diverse disciplines of science.
Her Cytotoxic T cell research incorporates themes from Defensin, Virus, Virology and CD8, Immune system.
Her most cited work include:
- Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. (642 citations)
- Methylation determines fibroblast activation and fibrogenesis in the kidney (439 citations)
- Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation (428 citations)
What are the main themes of her work throughout her whole career to date?
Claudia A. Müller spends much of her time researching Immunology, Molecular biology, Antigen, Human leukocyte antigen and Pathology.
Her Immunology study integrates concerns from other disciplines, such as Internal medicine and Disease.
The various areas that Claudia A. Müller examines in her Molecular biology study include Cell culture, Cell and Epitope, Antibody, Monoclonal antibody.
Her studies examine the connections between Antigen and genetics, as well as such issues in Cytotoxic T cell, with regards to CD8.
As a part of the same scientific study, she usually deals with the Human leukocyte antigen, concentrating on Allele and frequently concerns with Pathogenesis and HLA-DR.
She interconnects Glomerulonephritis, Kidney and Human cytomegalovirus in the investigation of issues within Pathology.
She most often published in these fields:
- Immunology (38.46%)
- Molecular biology (28.85%)
- Antigen (26.28%)
What were the highlights of her more recent work (between 2006-2019)?
- Immunology (38.46%)
- Human leukocyte antigen (20.51%)
- Cell biology (12.18%)
In recent papers she was focusing on the following fields of study:
Claudia A. Müller mainly focuses on Immunology, Human leukocyte antigen, Cell biology, Molecular biology and Allele.
Her research integrates issues of Disease and CD40 in her study of Immunology.
She has included themes like Malignant transformation and Nephritis in her Human leukocyte antigen study.
Her work in Molecular biology addresses subjects such as Cell culture, which are connected to disciplines such as CD146 and Mesenchymal stem cell.
Her Antigen research includes themes of T-Cell Antigen Receptor Specificity and Antigen presentation.
Her Laser capture microdissection study combines topics from a wide range of disciplines, such as Kidney and Pathology.
Between 2006 and 2019, her most popular works were:
- Methylation determines fibroblast activation and fibrogenesis in the kidney (439 citations)
- Tet3-Mediated Hydroxymethylation of Epigenetically Silenced Genes Contributes to Bone Morphogenic Protein 7-Induced Reversal of Kidney Fibrosis (87 citations)
- The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. (83 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
The scientist’s investigation covers issues in Immunology, Human leukocyte antigen, Epigenetics, Pathology and DNA methylation.
Immunology is closely attributed to CD40 in her study.
Her Human leukocyte antigen research is multidisciplinary, incorporating elements of Cancer, Kidney cancer, Metastasis, Renal cell carcinoma and Carcinoma.
Her Epigenetics study incorporates themes from Promoter, Cancer research, Methylation and DNA demethylation.
Her Pathology research is multidisciplinary, relying on both DNMT1, Kidney metabolism, Oncogene Protein p21, Primary tumor and Immunotherapy.
Her research in DNA methylation intersects with topics in Fibrosis, Fibroblast, Gene silencing and Kidney.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
